Intermolecular Revenue, Profits - IMI Quarterly Income Statement

Add to My Stocks
$1.35 $0.01 (0.75%) IMI stock closing price Aug 17, 2018 (Closing)

Looking at financial statements, along with the Intermolecular stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the IMI income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue growth of 1.24% when compared to the same period in the past. Revenue for year 2018 Q2 is $9.8M and has increased from $9.68M quarter on quarter as is evident when you compare the latest figures in the latest Intermolecular profit and loss statement with those of the prior corresponding period. Also see Intermolecular assets and Intermolecular free cash flow for a complete valuation of IMI stock.

View and download details of revenue and profits for Intermolecular for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Intermolecular Revenues or Net Sales
9.8M9.68M10.55M8.62M8.09M9.95M10.48M10.57M10.05M14.52M
Cost Of Goods Sold (COGS)2.86M3.37M3.71M2.87M2.54M2.98M3.46M3.45M4.13M4.79M
Intermolecular Gross Profit
6.94M6.29M6.86M5.74M5.54M6.95M7.04M7.11M7.59M9.72M
Research & Development Expense4.06M4.03M4.22M4.83M5.38M7.1M5.85M8.45M6.92M6.9M
Selling General & Admin Expense2.61M3.08M2.71M2.87M3.15M5.83M4.31M5.57M4.79M4.54M
Income Before Depreciation Depletion Amortization--0.81M-0.07M-1.96M-2.99M-5.98M-3.11M-6.91M-4.12M-1.72M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Intermolecular Pretax Income
--0.62M--1.82M-2.85M-5.83M-3.01M-6.77M-3.98M-1.67M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations--0.62M--1.83M-2.85M-5.84M-2.99M-6.78M-3.99M-1.68M
Extraordinary Items & Discontinued Operations----------
Intermolecular Profit/ Loss (Net Income)
--0.62M--1.83M-2.85M-5.84M-2.99M-6.78M-3.99M-1.68M
Average Shares used to compute Diluted EPS50.06M49.58M49.56M49.56M49.56M49.52M49.49M49.47M49.45M49.29M
Average Shares used to compute Basic EPS49.67M49.58M49.56M49.56M49.56M49.52M49.49M49.47M49.45M49.29M
Income Before Nonrecurring Items--0.62M--1.83M-2.85M-5.84M-2.99M-6.78M-3.99M-1.68M
Income from Nonrecurring Items----------
Intermolecular Earnings Per Share Basic Net
0.01-0.010.01-0.04-0.06-0.12-0.06-0.14-0.08-0.03
Intermolecular Earnings Per Share Diluted Net
0.01-0.010.01-0.04-0.06-0.12-0.06-0.14-0.08-0.03
EPS Diluted Before Nonrecurring Items0.01-0.010.00-0.04-0.06-0.12-0.06-0.14-0.08-0.03
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Intermolecular stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $9.8M for this quarter of 2018 Q2. Our Intermolecular revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Intermolecular try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The IMI financials along with Intermolecular historical stock prices provide a lot of details about the firm.

Intermolecular Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.72
Operating Margin
2.9
Net Profit Margin
5.1
Dividend Yield
0%